Gene · 9261
Papers3,346
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 3,346
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Heat Shock Protein 27, a Novel Downstream Target of Collagen Type XI alpha 1, Synergizes with Fatty Acid Oxidation to Confer Cisplatin Resistance in Ovarian Cancer Cells. | Cancers (Basel) | 2021 | 34638339 | PubTator, text mining | PubMed |
| Sulforaphane: A Broccoli Bioactive Phytocompound with Cancer Preventive Potential. | Cancers (Basel) | 2021 | 34638282 | PubTator, text mining | PubMed |
| Promyelocytic leukemia protein targets MK2 to promote cytotoxicity. | EMBO Rep | 2021 | 34633746 | PubTator, text mining | PubMed |
| Therapeutic MK2 inhibition blocks pathological vascular smooth muscle cell phenotype switch. | JCI Insight | 2021 | 34622803 | PubTator, text mining | PubMed |
| LncRNA RP11-499E18.1 Inhibits Proliferation, Migration, and Epithelial-Mesenchymal Transition Process of Ovarian Cancer Cells by Dissociating PAK2-SOX2 Interaction. | Front Cell Dev Biol | 2021 | 34621737 | PubTator, text mining | PubMed |
| CDKL5 kinase controls transcription-coupled responses to DNA damage. | EMBO J | 2021 | 34605059 | PubTator, text mining | PubMed |
| Phosphoproteomics Provides Novel Insights into the Response of Primary Acute Lymphoblastic Leukemia Cells to Microtubule Depolymerization in G1 Phase of the Cell Cycle. | ACS Omega | 2021 | 34604676 | PubTator, text mining | PubMed |
| T lymphocyte and monocyte subsets are dysregulated in type 1 diabetes patients with peripheral neuropathic pain. | Brain Behav Immun Health | 2021 | 34589782 | PubTator, text mining | PubMed |
| Targeting mutant p53 for cancer therapy: direct and indirect strategies. | J Hematol Oncol | 2021 | 34583722 | PubTator, text mining | PubMed |
| Interactions of Truncated Menaquinones in Lipid Monolayers and Bilayers. | Int J Mol Sci | 2021 | 34575937 | PubTator, text mining | PubMed |
| Fibronectin: Molecular Structure, Fibrillar Structure and Mechanochemical Signaling. | Cells | 2021 | 34572092 | PubTator, text mining | PubMed |
| Transcriptomic Analysis of HCN-2 Cells Suggests Connection among Oxidative Stress, Senescence, and Neuron Death after SARS-CoV-2 Infection. | Cells | 2021 | 34571838 | PubTator, text mining | PubMed |
| ISGylation drives basal breast tumour progression by promoting EGFR recycling and Akt signalling. | Oncogene | 2021 | 34556814 | PubTator, text mining | PubMed |
| Cyclosporin A: A Repurposable Drug in the Treatment of COVID-19? | Front Med (Lausanne) | 2021 | 34552938 | PubTator, text mining | PubMed |
| Downregulation of GNA15 Inhibits Cell Proliferation via P38 MAPK Pathway and Correlates with Prognosis of Adult Acute Myeloid Leukemia With Normal Karyotype. | Front Oncol | 2021 | 34552875 | PubTator, text mining | PubMed |
| Bio-informatics and in Vitro Experiments Reveal the Mechanism of Schisandrin A Against MDA-MB-231 cells. | Bioengineered | 2021 | 34550868 | PubTator, text mining | PubMed |
Granulocyte colony-stimulating factor promotes an aggressive phenotype of colon and breast cancer cells with biochemical changes investigated by single-cell Raman microspectroscopy and machine learning analysis. | Analyst | 2021 | 34543367 | PubTator, text mining | PubMed |
| Post-transcriptional screen of cancer amplified genes identifies ERBB2/Her2 signaling as AU-rich mRNA stability-promoting pathway. | Oncogenesis | 2021 | 34535639 | PubTator, text mining | PubMed |
| Heat Shock Protein Beta 1 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma. | Int J Gen Med | 2021 | 34531676 | PubTator, text mining | PubMed |
| METTL3-dependent MALAT1 delocalization drives c-Myc induction in thymic epithelial tumors. | Clin Epigenetics | 2021 | 34530916 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9261/papers?page=40